Nghi Co Nguyen MD, PhD, Abstract Co-Author: Research Grant, Koninklijke Philips NV

Peter F. Faulhaber MD, Abstract Co-Author: Speaker, Koninklijke Philips NV Grant, Koninklijke Philips NV Medical Advisor, MIM Software Inc

Raj Mohan Paspulati MD, Presenter: Research grant from Philips Healthcare

-To gain knowledge about current PET/MRI technology in the clinical practice -To learn about the potential strengths and weaknesses of FDG PET/MRI and PET/CT as well as potential added value of PET/MRI over PET/CT -To learn about the challenges and solutions for PET/MRI clinical workflow in the evaluation of colorectal cancer.  

In this Education Exhibit, we provide an update on the three hybrid PET/MRI systems currently available in the market. We then illustrate the strengths and weaknesses of FDG PET/MRI and PET/CT in case studies, as well as demonstrate the added value of PET/MRI in colorectal cancer staging and restaging, based on a sequential PET/MRI system (Ingenuity TF PET/MRI, Philips Healthcare). The workflow of PET/MRI for the evaluation of colorectal cancer is challenging not at least because of the co-administration of glucagon during the MRI examination, which may affect the FDG PET image quality. We discuss the unique attributes of clinical workflow to optimize the PET/MRI examination in terms of image quality, time efficiency and patient comfort. Summary: This Education Exhibit provides helpful information about current clinical PET/MRI systems and illustrate the strengths and weaknesses of PET/MRI compared with PET/CT, as well as discuss about challenges and solutions for clinical workflow.  

http://abstract.rsna.org/uploads/2014/14008081/14008081_jlps.pdf

Nguyen, N, Faulhaber, P, Paspulati, R, Added Value of FDG PET/MRI Compared with PET/CT in Patients with Colorectal Cancer and Workflow Solutions for PET/MRI Examination.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14008081.html